Immunotechnology at Lund University applies immunology, biomedicine, and protein science to understand disease mechanisms and support the development of diagnostic and therapeutic technologies. The programme combines experimental and computational training, with research-led learning in areas such as biomarkers, therapeutic antibodies, and immune responses.
The Immunotechnology program at Lund University integrates immunology, biomedicine, and protein science to explore disease mechanisms and foster the development of diagnostic and therapeutic technologies. This comprehensive course offers a blend of experimental and computational training, enabling students to engage in research-led learning in critical areas such as biomarkers, therapeutic antibodies, and immune responses.
The program emphasizes research and combines subject-focused coursework with supervised work and an independent thesis project. The curriculum is organized around immunology and technology development, with robust training in data analysis and interpretation.
Students undertake an independent thesis project under supervision, designed to showcase their ability to formulate research questions, apply appropriate methodologies, analyze results, and communicate findings in a scientific format.
Applicants must satisfy the general entry requirements for third-cycle (doctoral) studies and study programs at Lund University. Specific GRE/GMAT/GPA requirements are not stipulated for this program.
Graduates of the Immunotechnology program are well-equipped to pursue careers in various sectors, including research institutions, pharmaceutical companies, and healthcare organizations. They may find opportunities in areas such as diagnostic development, therapeutic research, and academic positions, contributing to advancements in immunology and biotechnology.
Shortlist scholarships and plan your application — free guidance from our advisors.